Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLARA ACTIVE PHARMA SCIENCES LIMITED Capital/Financing Update 2026

Mar 24, 2026

61842_rns_2026-03-24_64d2ecc2-c0ab-432d-a204-9e5e089a5153.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Corporate Office: Solara Active Pharma Sciences Limited TICEL Bio Park, 6th Floor, Module No. 601, 602, 603, Phase II – CSIR Road, Taramani, Chennai, Tamil Nadu – 600113. Tel: +91 44 4344 6700 Fax: +91 44 47406190 E-mail: [email protected] Website: www.solara.co.in

==> picture [181 x 70] intentionally omitted <==

Date: March 24, 2026

Date: March 24, 2026
The BSE LimitedPhiroze Jeejeebhoy TowersDalalStreet,Mumbai – 400 001 The National Stock Exchange of India LimitedExchange Plaza, C-1, Block G, Bandra-Kurla Complex,Bandra (E),Mumbai – 400 051
Scrip Code: 541540, 890202 Symbol: SOLARA, SOLARAPP1

Dear Sir / Madam,

==> picture [445 x 4] intentionally omitted <==

==> picture [445 x 5] intentionally omitted <==

==> picture [445 x 5] intentionally omitted <==

==> picture [445 x 4] intentionally omitted <==

Sub: Intimation under Regulation 30 and 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Outcome of Rights Issue Committee Meeting dated March 24, 2026

==> picture [445 x 4] intentionally omitted <==

This is to inform you that the Meeting of the Rights Issue Committee of the Board of Directors of the Company held today i.e., Tuesday, March 24, 2026 has inter alia considered and approved the making of Second & Final call of ₹ 112.50/- per equity shares (₹ 3.00/- towards face value and ₹ 109.50/- towards securities premium) per Rights Share in respect of partly-paid Rights Shares, on Rights basis, pursuant to the Letter of Offer dated May 09, 2024. Rights Issue Committee has fixed Thursday, April 02, 2026, as the Record date for the purpose of determining the holders of partly paid-up Equity Shares to whom the call notice will be dispatched for payment of the call.

==> picture [445 x 5] intentionally omitted <==

==> picture [445 x 4] intentionally omitted <==

Details under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 has been enclosed herewith as Annexure I .

==> picture [445 x 5] intentionally omitted <==

==> picture [445 x 4] intentionally omitted <==

==> picture [445 x 5] intentionally omitted <==

==> picture [445 x 4] intentionally omitted <==

The Rights Issue Committee Meeting commenced at 9.30 A.M. and concluded at 9.55 A.M.

==> picture [445 x 5] intentionally omitted <==

==> picture [445 x 4] intentionally omitted <==

==> picture [445 x 5] intentionally omitted <==

This is for your information and records.

==> picture [445 x 4] intentionally omitted <==

==> picture [445 x 5] intentionally omitted <==

==> picture [445 x 4] intentionally omitted <==

==> picture [445 x 5] intentionally omitted <==

Yours faithfully, For Solara Active Pharma Sciences Limited

==> picture [445 x 5] intentionally omitted <==

==> picture [445 x 4] intentionally omitted <==

==> picture [445 x 5] intentionally omitted <==

POOJA JAYA Digitally signed by POOJA JAYA KUMAR KUMAR Date: 2026.03.24 10:09:03 +05'30' Pooja Jaya Kumar Company Secretary and Compliance Officer ICSI Membership No. A57415 Encl.: as above

==> picture [445 x 4] intentionally omitted <==

==> picture [445 x 5] intentionally omitted <==

==> picture [445 x 4] intentionally omitted <==

==> picture [445 x 5] intentionally omitted <==

==> picture [445 x 4] intentionally omitted <==

==> picture [445 x 5] intentionally omitted <==

==> picture [445 x 4] intentionally omitted <==

==> picture [445 x 5] intentionally omitted <==

==> picture [445 x 4] intentionally omitted <==

==> picture [445 x 5] intentionally omitted <==

==> picture [445 x 5] intentionally omitted <==

==> picture [445 x 4] intentionally omitted <==

==> picture [445 x 5] intentionally omitted <==

Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636 Registered Office: 9th Floor, ‘Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703; Tel: +91-22-20870033

Corporate Office: Solara Active Pharma Sciences Limited TICEL Bio Park, 6th Floor, Module No. 601, 602, 603, Phase II – CSIR Road, Taramani, Chennai, Tamil Nadu – 600113. Tel: +91 44 4344 6700 Fax: +91 44 47406190 E-mail: [email protected] Website: www.solara.co.in

==> picture [181 x 70] intentionally omitted <==

Annexure – I

Details under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 read along with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015, read with Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026

==> picture [445 x 4] intentionally omitted <==

==> picture [459 x 314] intentionally omitted <==

----- Start of picture text -----

Sr. Particulars Remarks
No.
1. Forfeiture of shares Not Applicable.
2. Reissue of forfeited shares or Not Applicable.
securities, or the issue of shares or
securities held in reserve for future
issue or the creation in any form or
manner of new shares or securities or
any other rights, privileges or benefits
to subscribe to
3. Proposal to issue any class of Not Applicable
securities;
4. Alterations of capital, including calls; Second & Final call of ₹ 112.50/- per equity shares
(₹ 3.00/- towards face value and ₹ 109.50/- towards
securities premium) per Rights Share in respect of
partly paid Rights Shares, on Rights basis, pursuant
to the Letter of Offer dated May 09, 2024.
5. Change in the terms regarding Not Applicable
redemption/cancellation/retirement in
whole or in part of any securities issued
by the listed entity

----- End of picture text -----

==> picture [445 x 4] intentionally omitted <==

==> picture [445 x 5] intentionally omitted <==

For Solara Active Pharma Sciences Limited

==> picture [445 x 5] intentionally omitted <==

==> picture [445 x 4] intentionally omitted <==

==> picture [445 x 5] intentionally omitted <==

==> picture [445 x 40] intentionally omitted <==

----- Start of picture text -----

POOJA Digitally signed by
JAYA POOJA JAYA KUMAR Date: 2026.03.24
KUMAR 10:09:23 +05'30'

----- End of picture text -----

Pooja Jaya Kumar Company Secretary and Compliance Officer ICSI Membership No. A57415

Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636 Registered Office: 9th Floor, ‘Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703; Tel: +91-22-20870033